Related references
Note: Only part of the references are listed.Proteasome-Generated cis-Spliced Peptides and Their Potential Role in CD8+ T Cell Tolerance
Artem Mansurkhodzhaev et al.
FRONTIERS IN IMMUNOLOGY (2021)
Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and cis-Spliced Zwitter Epitope Candidates in Type 1 Diabetes
Michele Mishto et al.
FRONTIERS IN IMMUNOLOGY (2021)
Commentary: An In Silico - In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
Ilan Beer
FRONTIERS IN IMMUNOLOGY (2021)
Large database for the analysis and prediction of spliced and non-spliced peptide generation by proteasomes
Gerd Specht et al.
SCIENTIFIC DATA (2020)
What We See, What We Do Not See, and What We Do Not Want to See in HLA Class I Immunopeptidomes
Michele Mishto
PROTEOMICS (2020)
Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing
Wayne Paes et al.
FRONTIERS IN IMMUNOLOGY (2020)
Proteolytic dynamics of human 20S thymoproteasome
Ulrike Kuckelkorn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis
Chiara Dianzani et al.
CELLS (2019)
Proteasomal degradation within endocytic organelles mediates antigen cross-presentation
Debrup Sengupta et al.
EMBO JOURNAL (2019)
Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection
Wayne Paes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
An in silico-in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
Michele Mishto et al.
FRONTIERS IN IMMUNOLOGY (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Mapping the MHC Class I-Spliced Immunopeptidome of Cancer Cells
Juliane Liepe et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Why do proteases mess up with antigen presentation by re-shuffling antigen sequences?
Juliane Liepe et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naive CD8+T Cells in Type 1 Diabetic and Healthy Donors
Sergio Gonzalez-Duque et al.
CELL METABOLISM (2018)
A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands
Pouya Faridi et al.
SCIENCE IMMUNOLOGY (2018)
Post-Translational Peptide Splicing and T Cell Responses
Michele Mishto et al.
TRENDS IN IMMUNOLOGY (2017)
Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
Seung-Min Shin et al.
NATURE COMMUNICATIONS (2017)
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis
Chiara Dianzani et al.
SCIENTIFIC REPORTS (2017)
Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8+ T Cells during Bacterial Infection
Anouk C. M. Platteel et al.
CELL REPORTS (2017)
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
Qiong J. Wang et al.
CANCER IMMUNOLOGY RESEARCH (2016)
CD8+ T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products
Anouk C. M. Platteel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
Juliane Liepe et al.
SCIENCE (2016)
Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes
F. Ebstein et al.
SCIENTIFIC REPORTS (2016)
The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing
Kathrin Textoris-Taube et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules
Celia R. Berkers et al.
JOURNAL OF IMMUNOLOGY (2015)
Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes
Juliane Liepe et al.
ELIFE (2015)
The ubiquitin-proteasome system and activation of NF-kappa B: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression
Yelena Kravtsova-Ivantsiv et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
Driving Forces of Proteasome-catalyzed Peptide Splicing in Yeast and Humans
Michele Mishto et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome
Alexandre Dalet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
An antigenic peptide produced by reverse splicing and double asparagine deamidation
Alexandre Dalet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The 20S Proteasome Splicing Activity Discovered by SpliceMet
Juliane Liepe et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Transpeptidation and reverse proteolysis and their consequences for immunity
Celia R. Berkers et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
An antigenic peptide produced by peptide splicing in the proteasome
N Vigneron et al.
SCIENCE (2004)
Immune recognition of a human renal cancer antigen through post-translational protein splicing
K Hanada et al.
NATURE (2004)
Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes -: Evidence for peptide-induced channel opening in the α-rings
AF Kisselev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome
G Schmidtke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
